Anika Therapeutics, Inc. (ANIK)
9.64
+0.12
(+1.26%)
USD |
NASDAQ |
Dec 10, 16:00
9.65
+0.01
(+0.10%)
After-Hours: 20:00
Anika Therapeutics Profit Margin (Quarterly): -11.41% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Stryker Corp. | 14.18% |
| Perspective Therapeutics, Inc. | -12.43K% |
| Electromed, Inc. | 12.65% |
| Xtant Medical Holdings, Inc. | 3.93% |
| VolitionRX Ltd. | -862.4% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -9.18% |
| Return on Assets | -7.03% |
| Return on Invested Capital | -7.88% |
| Gross Profit Margin (Quarterly) | 56.02% |
| Operating Margin (Quarterly) | -11.62% |
| Return on Net Operating Assets | -11.39% |